Suppression by glutamate of proliferative activity through glutathione depletion mediated by the cystine/glutamate antiporter in mesenchymal C3H10T1/2 stem cells

Journal of Cellular Physiology

Volumn 213, Issue 3, 2007, Pages 721-729

  Iemata, Mika ^b   Takarada, Takeshi ^b   Hinoi, Eiichi ^b   Taniura, Hideo ^b   Yoneda, Yukio ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOHEXENONE; ANTIPORTER; BUTHIONINE SULFOXIMINE; CELL PROTEIN; CYSTINE GLUTAMATE ANTIPORTER; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMIC ACID; GLUTATHIONE; GLUTATHIONE SYNTHASE INHIBITOR; IONOTROPIC RECEPTOR; MESSENGER RNA; PROTEIN 4F2HC; PROTEIN XCT; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE OVEREXPRESSION; GLUTATHIONE DEPLETION; GLUTATHIONE METABOLISM; MESENCHYMAL STEM CELL; MOUSE; MUSCLE CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIPORTERS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CYSTINE; DNA PRIMERS; FORMAZANS; GENES, REPORTER; GLUTAMIC ACID; GLUTATHIONE; L-LACTATE DEHYDROGENASE; LUCIFERASES; MESODERM; MICE; PROPIDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; TAQ POLYMERASE; TETRAZOLIUM SALTS;

EID: 35848954756     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21145     Document Type: Article

References (40)

1. Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res 9:641-650.
2. Chenu C, Serre CM, Raynal C, Burt-Pichat B, Delmas PD. 1998. Glutamate receptors are expressed by bone cells and are involved in bone resorption. Bone 22:295-299.
3. D'Amico M, Wu K, Fu M, Rao M, Albanese C, Russell RG, Lian H, Bregman D, White MA, Pestell RG. 2004. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements. Cancer Res 64:4122-4130.
4. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. 1987. Bone marrow osteogenic stem cells: In vitro cultivation and transplantation indiffusion chambers. Cell Tissue Kinet 20:263-272.
5. Herlin PM, James JH, Joffe SN, Kulneff-Herlin AE, Fischer JE. 1982. Effect of jejunoileal bypass on plasma and brain amino acids in the rat. J Neurochem 38:1170-1173.
6. Hinoi E, Fujimori S, Nakamura Y, Yoneda Y. 2001. Group III metabotropic glutamate receptors in cultured rat calvarial osteoblasts. Biochem Biophys Res Commun 281:341-346.
7. Hinoi E, Fujimori S, Takemori A, Kurabayashi H, Nakamura Y, Yoneda Y. 2002a. Demonstration of expression of mRNA for particular AMPA and kainate receptor subunits in immature and mature cultured rat calvarial osteoblasts. Brain Res 943:112-116.
8. Hinoi E, Fujimori S, Takarada T, Taniuta H, Yoneda Y. 2002b. Facilitation of glutamate release by ionotropic glutamate receptors in osteoblasts. Biochem Biophys Res Commun 297:452-458.
9. Hinoi E, Fujimori S, Yoneda Y. 2003. Modulation of cellular differentiation by N-methyl-D-aspartate receptors in osteoblasts. FASEB J 17:1532-1534.
10. Hinoi E, Wang L, Takemori A, Yoneda Y. 2005. Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage. Biochem Pharmacol 70:70-81.
11. Hinoi E, Fujimori S, Wang L, Hojo H, Uno K, Yoneda Y. 2006. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J Biol Chem 281:18015-18024.
12. Hinoi E, Takarada T, Uno K, Inoue M, Murafuji Y, Yoneda Y. 2007. Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter. Am J Pathol 170: 1277-1290.
13. Hollmann M, Heinemann S. 1994. Cloned glutamate receptors. Ann Rev Neurosci 17:31-108.
14. Kato S, Negishi K, Mawatari K, Kuo CH. 1992. A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion. Neuroscience 48:903-914.
15. Kim JS, Schmid-Burgk W, Claus D, Kornhuber HH. 1982. Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr 232:299-304.
16. Kraus KH, Kirker-Head C. 2006. Mesenchymal stem cells and bone regeneration. Vet Surg 35:232-242.
17. Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D, Skerry TM. 1999. Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 25:631-637.
18. Lee JS, Surh YJ. 2005. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 224:171-184.
19. McNearney T, Speegle D, Lawand N, Lisse J, Westlund KN. 2000. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 27:739-745.
20. Minguell JJ, Erices A, Conget P. 2001. Mesenchymal stem cells. Exp Biol Med 226:507-520.
21. Motohashi H, Yamamoto M. 2004. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549-557.
22. Pacheco R, Oliva H, Martinez-Navio JM, Climent N, Ciruela F, Gatell JM, Gallart T, Mallol J, Lluis C, Franco R. 2006. Glutamate released by dendritic cells as a novel modulator of T cell activation. J Immunol 177:6695-6704.
23. Peet NM, Grabowski PS, Laketic-Ljubojevic I, Skerry TM. 1999. The glutamate receptor antagonist MK801 modulates bone resorption in vitro by a mechanism predominantly involving osteoclast differentiation. FASEB J 13:2179-2185.
24. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, Prockop DJ. 1995. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in irradiated mice. Proc Natl Acad Sci USA 92:4857-4861.
25. Plaitakis A, Berl S, Yahr MD. 1982. Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder. Science 216:193-196.
26. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
27. Sato H, Fujiwara K, Sagara J, Bannai S. 1995. Induction of cystine transport activity in mouse peritoneal macrophages by bacterial lipopolysaccharide. Biochem J 310:547-551.
28. Shih AY, Erb H, Sun X, Toda S, Kalivas PW, Murphy TH. 2006. Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J Neurosci 26:10514-10523.
29. Skerry TM, Genever PG. 2001. Glutamate signalling in non-neuronal tissues. Trends Pharmacol Sci 22:174-181.
30. Suk-Kww T, Seok-Hyn L, Jae-Sik P, Gun-II I. 2006. Mesenchymal stem cells for tissue engineering and regenerative medicine. Biomed Mater 1:63-71.
31. 3H]glutamate in cultured rat calvarial osteoblasts. Biochem Pharmacol 68: 177-184.
32. Taylor SM, Jones PA. 1979. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779.
33. Wang L, Hinoi E, Takemori A, Takarada T, Yoneda Y. 2005a. Abolition of chondral mineralization by group III metabotropic glutamate receptors expressed in rodent cartilage. Br J Pharmacol 146:732-743.
34. Wang L, Hinoi E, Takemori A, Yoneda Y. 2005b. Release of endogenous glutamate by AMPA receptors expressed in cultured rat costal chondrocytes. Biol Pharm Bull 28:990-993.
35. Wang L, Hinoi E, Takemori A, Nakamichi N, Yoneda Y. 2006. Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine/glutamate antiporter. J Biol Chem 281:24553-24565.
36. Wisden W, Seeburg PH. 1993. Mammalian ionotropic glutamate receptors. Curr Opin Neurobiol 3:291-298.
37. 3H]glutamate binding sites in rat adrenal medulla. Brain Res 383:387-391.
38. 3H]Glutamate binding sites in the rat pituitary. Neurosci Res 3:430-435.
39. Yoneda Y, Kuramoto N, Kitayama T, Hinoi E. 2001. Consolidation of transient ionotropic glutamate signals through nuclear transcription factors in the brain. Prog Neurobiol 63:697-719.
40. Zhang Y, Gordon GB. 2004. A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther 3:885-893.